Cequa
Reason Subpotent and Presence of Particulates .
17,898 recalls, newest first
Reason Subpotent and Presence of Particulates .
Reason Presence of Foreign Tablets/Capsules
Reason Subpotent Drug
Reason Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities
Reason Presence of foreign substance: identified as activated carbon.
Reason Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP
Reason Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.
Reason Presence of Particulate Matter: particulate matter identified as an insect in one vial.
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Presence of Foreign Tablet/Capsule
Reason Subpotent Drug
Reason Temperature Abuse: Product exposed to temperature outside specified limits.
Reason Temperature Abuse: Product exposed to temperature outside specified limits.
Reason Temperature Abuse: Product exposed to temperature outside specified limits.
Reason Temperature Abuse: Product exposed to temperature outside specified limits.
Reason Temperature Abuse: Product exposed to temperature outside specified limits.
Reason Temperature Abuse: Product exposed to temperature outside specified limits.
Reason Temperature Abuse: Product exposed to temperature outside specified limits.
Reason Temperature Abuse: Product exposed to temperature outside specified limits.
Reason CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.